Quest Diagnostics Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 10 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 216.15.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Quest Diagnostics Inc is 8.10, ranking 20 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 2.81B, representing a year-over-year increase of 7.06%, while its net profit experienced a year-over-year increase of 11.36%.
Key Metrics
The current valuation score of Quest Diagnostics Inc is 6.63, ranking 48 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 22.07, which is 7.86% below the recent high of 23.81 and 26.62% above the recent low of 16.20.
The current earnings forecast score of Quest Diagnostics Inc is 7.50, ranking 38 out of 75 in the Healthcare Providers & Services industry. The average price target is 198.00, with a high of 215.00 and a low of 169.18.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Quest Diagnostics Inc is 6.82, ranking 30 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 209.04 and the support level at 188.33, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Quest Diagnostics Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 99.89%, representing a quarter-over-quarter decrease of 0.33%. The largest institutional shareholder is The Vanguard, holding a total of 14.34M shares, representing 13.05% of shares outstanding, with 4.91% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quest Diagnostics Inc is 9.69, ranking 1 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.65. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Quest Diagnostics Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
